IntelliGen Technology is dedicated to the research, development, and promotion of intelligent medical imaging technologies. The company specializes in transforming traditional black-and-white 2D medical images into vivid 3D color visualizations, enhancing the quality and efficiency of clinical diagnosis, surgical planning, and medical education. With independently developed AI technologies, IntelliGen Technology has established collaborations with several leading medical centers in Taiwan and is actively expanding into international markets, including ongoing discussions with partners in Germany and Luxembourg. Upholding a spirit of innovation, the company integrates cloud platforms and cross-device applications to drive the digital transformation of medical imaging, aiming to become a key force in advancing Taiwan's smart healthcare industry.

Inventec Corporation, founded in 1975 and headquartered in Taipei, is a global leader in ICT solutions. With expertise in cloud computing, IoT, AI, and smart manufacturing, Inventec is actively expanding into smart healthcare, developing innovative technologies to enhance medical services and digital care.

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.

Every day, our more than 130,000 employees across the world are blending heart, science, and ingenuity to profoundly change the trajectory of health for humanity.

JW Diagnostics Inc. provides comprehensive and high-quality tests and molecular analysis services for precision medicine in the fields of preventive health management, maternal and child care, and medical decision-making for cancer therapies by cooperating with Taipei Medical University.

Originating from the automatic nucleic acid department established by “Taigen Bioscience Co.,Ltd.”in 2000, LabTurbo has been focusing on the development of nucleic acid-applied automatic technology in the past 20 years. Due to the substantial progress of the global gene detection and molecular diagnostics market, LabTurbo Biotech Corporation was officially established in June 2019 for the research, manufacture and provision of fast, accurate, automated, and high throughput gene detection systems and kits. We invested the funds in the development of fully automated, full-process gene testing systems, and diversified the applications of LabTurbo AIOSP-qPCR System for global market expansion.

LabTurbo systems use the proprietary membrane column and vacuum technology for fully automated nucleic acid extraction. Due to the outstanding detection sensitivity, LabTurbo systems were used by American Red Cross to per form lyme disease nucleic acid testing in nearly 90,000 transfusion blood samples. The research results were published on the prestigious medical journal “The New England Journal of Medicine (NEJM),”and subsequently obtained the FDA approval of Class III medical device. These honors proved that LabTurbo’s automated systems and products are in line with the top standards around the world.

LabTurbo will strive to extend the business to the global gene detection market and expand the applications of automated gene testing.

Founded in 2013, Leadgene Biomedical, Inc. is an ISO 13485 and GMP certified biotechnology company. Our profession lies in our attention to detail. Based on the core competence, products are designed, developed and manufactured by ourselves. We focus on the development of monoclonal antibody, protein and the application platforms, including IVD kits development, antibody-drug development, and related reagents for both academic research and in vitro diagnostic use. We have established pilot-scale manufacturing and are devoted to ensuring high -quality standards. We provide high-quality products, customised service, CRO and CDMO service, etc. Our mission is to act as a focal point to support the domestic stockpile of raw materials and inject new energy into Taiwan's biomedical industry.

千才生醫成立於102年，並進駐新竹生物醫學園區，從事於高科技光電模組及系統之專業廠商，應用於光醫療器材相關領域。已累積成熟的光機電研發及生產技術，結合生物醫學等，專注生產醫療用光療儀，光生化雷射治療儀和醫療放射線系統之檢測探測器。

Lixel's glasses-free 3D floating image and air-touch interaction technology have not only transformed people's visual and interactive experiences but also pioneered a new human-machine interface, enabling individuals to work, learn, and socialize in a more intuitive and humane manner.

We have developed hardware product LFIAT, software product SpatiumNEX, and solutions for hospitals and medical schools, allowing them to input patients' MRI and CT images into the solution through the following process: segmentation, reconstruction of 3D models, and conversion into highly immersive 3D floating image. Users can manipulate and edit the 3D floating image in air, enhancing the efficiency of medical care and education. Through the solution's remote connection functionality, individuals in different locations can simultaneously view and edit 3D floating image, creating innovative applications for remote healthcare.

After years of effort, in 2023, we began collaborating with several hospitals and medical schools, making substantial progress and validating that we not only bring new experiences to doctors, teachers, and students but also assist them in addressing pain points and creating new value.

MedFirst was first established on December 4, 1990. With more than 20 years of rich experience as a leading medical and healthcare supplier, we carry more than 30,000 products in 31 categories.

Business/Items
(1) Medical, health, care and specialty supplies stores
(2) Professional medical supplier for sale at the hospitals
(3) Professional store management and planning of hospital industry
(4) Home and health consultant